马瑞松,王圣

• 1:海南省人民医院心内科海南医科大学附属海南医院

摘要(Abstract)：

心力衰竭（HF）是全球范围内常见且影响广泛的心血管病。近年来，经皮去肾神经术（RDN）在HF治疗中的应用，逐步成为新的研究热点。RDN通过降低交感神经活性，减轻心肌损伤，抑制心室重构、改善心脏功能，进而改善HF患者预后。本文旨在总结RDN在HF治疗中的最新进展，从而为HF的治疗提供新的思路。

关键词(KeyWords)： 心力衰竭;经皮去肾神经术;射频消融

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 马瑞松,王圣

参考文献(References)：

• [1] Suzuki S,Kitai T,Skoularigis J,et al.Catheter ablation for atrial fibrillation in patients with heart failure:current evidence and future opportunities[J].J Pers Med,2023,13(9):1394.DOI:10.3390/jpm13091394.
• [2]Shahim B,Kapelios CJ,Savarese G,et al.Global public health burden of heart failure:an updated review[J].Card Fail Rev,2023,9:e11.DOI:10.15420/cfr.2023.05.
• [3]Wang H,Chai K,Du M,et al.Prevalence and incidence of heart failure among urban patients in China:a national population-based analysis[J].Circ Heart Fail,2021,14(10):e008406.DOI:10.1161/CIRCHEARTFAILURE.121.008406.
• [4]Ramchandra R,Barrett CJ.Regulation of the renal sympathetic nerves in heart failure[J].Front Physiol,2015,6:238.DOI:10.3389/fphys.2015.00238.
• [5]Cleland JGF,Bunting KV,Flather MD,et al.Beta-blockers for heart failure with reduced,mid-range,and preserved ejection fraction:an individual patient-level analysis of double-blind randomized trials[J].Eur Heart J,2018,39(1):26-35.DOI:10.1093/eurheartj/ehx564.
• [6]郭炳辰,唐昊,李光辉,等.慢性心力衰竭神经调节治疗技术的应用与研究进展[J].中国介入心脏病学杂志,2023,31(8):603-608.DOI:10.3969/j.issn.1004-8812.2023.08.007.
• [7]中国高血压防治指南修订委员会,高血压联盟(中国),中国医疗保健国际交流促进会高血压病学分会,等.中国高血压防治指南(2024年修订版)[J].中华高血压杂志,2024,32(7):603-700.DOI:10.16439/j.issn.1673-7245.2024.07.002.
• [8]McEvoy JW,McCarthy CP,Bruno RM,et al.2024ESC Guidelines for the management of elevated blood pressure and hypertension[J].Eur Heart J,2024,45(38):3912-4018.DOI:10.1093/eurheartj/ehae178.
• [9]周力力,张毅,王捷.经皮去肾神经术治疗高血压临床试验的展望[J].中国介入心脏病学杂志,2024,32(6):334-337.DOI:10.3969/j.issn.1004-8812.2024.06.007.
• [10] Chen H,Shen L,Ge J.Clinical benefits of renal denervation besides blood pressure reduction[J].Cardiology Plus,2018,3(2):58-65.DOI:10.4103/cp.cp_10_18.
• [11] Tsigkas G,Apostolos A,Despotopoulos S,et al.Heart failure and atrial fibrillation:new concepts in pathophysiology,management,and future directions[J].Heart Fail Rev,2022,27(4):1201-1210.DOI:10.1007/s10741-021-10133-6.
• [12]Yu L,Huang B,Wang Z,et al.Impacts of renal sympathetic activation on atrial fibrillation:the potential role of the autonomic cross talk between kidney and heart[J].J Am Heart Assoc,2017,6(3):e004716.DOI:10.1161/JAHA.116.004716.
• [13] Steinberg SF.N-Tertaining a new signaling paradigm for the cardiomyocyte β1-Adrenergic Receptor[J].J Cardiovasc Pharmacol,2022,80(3):328-333.DOI:10.1097/FJC.0000000000001194.
• [14]Willeford A,Suetomi T,Nickle A,et al.CaMKII δ-mediated inflammatory gene expression and inflammasome activation in cardiomyocytes initiate inflammation and induce fibrosis[J].JCI Insight,2018,3(12):e97054.DOI:10.1172/jci.insight.97054.
• [15]Zhang Z,Yang Z,Wang S,et al.Targeting MAPK-ERK/JNK pathway:a potential intervention mechanism of myocardial fibrosis in heart failure[J].Biomed Pharmacother,2024,173:116413.DOI:10.1016/j.biopha.2024.116413.
• [16] Gong G,Wan W,Zhang X,et al.Management of ROS and regulatory cell death in myocardial ischemia-reperfusion injury[J].Mol Biotechnol,2025,67(5):1765-1783.DOI:10.1007/s1203 3-024-01173-y.
• [17]Tsuchimochi H,Nakamoto T,Matsukawa K.Centrally evoked increase in adrenal sympathetic outflow elicits immediate secretion of adrenaline in anaesthetized rats[J].Exp Physiol,2010,95(1):93-106.DOI:10.1113/expphysiol.2009.048553.
• [18]Nadaud S,Flamant M,Le Goff W,et al.Transcriptomic and lipidomic mapping of macrophages in the hub of chronic beta-adrenergic-stimulation unravels hypertrophy-,proliferation-,and lipid metabolism-related genes as novel potential markers of early hypertrophy or heart failure[J].Biomedicines,2022,10(2):221.DOI:10,3390/biomedicines 10020221.
• [19]Esler M,Eisenhofer G,Chin J,et al.Is adrenaline released by sympathetic nerves in man?[J].Clin Auton Res,1991,1(2):103-108.DOI:10.1007/BF01826204.
• [20]Mahata SK,Zheng H,Mahata S,et al.Effect of heart failure on catecholamine granule morphology and storage in chromaffin cells[J].J Endocrinol,2016,230(3):309-323.DOI:10.1530/JOE-16-0146.
• [21]Yano H,Onoue K,Tokinaga S,et al.Overexpression of GRK2in vascular smooth muscle leads to inappropriate hypertension and acute heart failure as in clinical scenario 1[J].Sci Rep,2023,13(1):7707.DOI:10.1038/s41598-023-34209-5.
• [22]Liu Q,Wang T,Yu H,et al.Interaction between interleukin-1beta and angiotensin II receptor 1 in hypothalamic paraventricular nucleus contributes to progression of heart failure[J].J Interferon Cytokine Res,2014,34(11):870-875.DOI:10.1089/jir.2013.0159.
• [23]Nishihara M,Takesue K,Hirooka Y.Olmesartan combined with renal denervation reduces blood pressure in association with sympatho-inhibitory and aldosterone-reducing effects in hypertensive mice with chronic kidney disease[J].Clin Exp Hypertens,2019,41(3):211-219.DOI:10.1080/10641963.2018.1465075.
• [24]Ameer OZ.Hypertension in chronic kidney disease:What liesbehind the scene[J].Front Pharmacol,2022,13:949260.DOI:10.3389/fphar.2022.949260.
• [25]Zucker IH,Xiao L,Haack KK.The central renin-angiotensin system and sympathetic nerve activity in chronic heart failure[J].Clin Sci(Lond),2014,126(10):695-706.DOI:10.1042/CS20130294.
• [26]Man o lis AA,Manolis TA,M anolis AS.Neurohumoral activation in heart failure[J].Int J Mol Sci,2023,24(20):15472.DOI:10.3390/ijms242015472.
• [27]Cuthbert JJ,Pellicori P,Clark AL.Cardiovascular outcomes with sacubitril-valsartan in heart failure:emerging clinical data[J].Ther Clin Risk Manag,2020,16:715-726.DOI:10.2147/TCRM.S234772.
• [28]Kon V,Yared A,Ichikawa I.Role of renal sympathetic nerves in mediating hypoperfusion of renal cortical microcirculation in experimental congestive heart failure and acute extracellular fluid volume depletion[J].J Clin Invest,1985,76(5):1913-1920.DOI:10.1172/JCI112187.
• [29]Cody RJ,Ljungman S,Covit AB,et al.Regulation of glomerular filtration rate in chronic congestive heart failure patients[J].Kidney Int,1988,34(3):361-367.DOI:10.1038/ki.1988.189.
• [30]Seino Y,Shimai S,Tanaka K,et al.Cardiovascular circulatory adjustments and renal function in acute heart failure[J].Jpn Circ J,1989,53(2):180-190.DOI:10.1253/jcj.53.180.
• [31]Katsurada K,Ogoyama Y,Imai Y,et al.Renal denervation based on experimental rationale[J].Hypertens Res,2021,44(11):1385-1394.DOI:10.1038/s41440-021-00746-7.
• [32] Katsurada K,Shinohara K,Aoki J,et al.Renal denervation:basic and clinical evidence[J].Hypertens Res,2022,45(2):198-209.DOI:10.1038/s41440-021-00827-7.
• [33]Honetschl??gerováZ,HuskováZ,KikerlováS,et al.Renal sympathetic denervation improves pressure-natriuresis relationship in cardiorenal syndrome:insight from studies with Ren-2transgenic hypertensive rats with volume overload induced using aorto-caval fistula[J].Hypertens Res,2024,47(4):998-1016.DOI:10.103 8/s41440-024-01583-0.
• [34]Huang TC,Lo LW,Chou YH,et al.Renal denervation reverses ventricular structural and functional remodeling in failing rabbit hearts[J].Sci Rep,2023,13(1):8664.DOI:10.1038/s41598-023-35954-3.
• [35] Polhemus DJ,Trivedi RK,Gao J,et al.Renal sympathetic denervation protects the failing heart via inhibition of neprilysin activity in the kidney[J].J Am Coll Cardiol,2017,70(17):2139-2153.DOI:10.1016/j.jacc.2017.08.056.
• [36]Miklovic M,Gawrys O,Honetschl??gerováZ,et al.Renal denervation improves cardiac function independently of afterload and restores myocardial norepinephrine levels in a rodent heart failure model[J].Hypertens Res,2024,47(10):2718-2730.DOI:10.1038/s41440-024-01580-3.
• [37]Katsurada K,Nandi SS,Zheng H,et al.GLP-1 mediated diuresis and natriuresis are blunted in heart failure and restored by selective afferent renal denervation[J].Cardiovasc Diabetol,2020,19(1):57.DOI:10.1186/s12933-020-01029-0.
• [38]Liang X,Shang S,Bai Z,et al.Effects of renal denervation on gap junction in high-pacing-induced heart failure dogs[J].Anatol J Cardiol,2024,28(9):429-436.DOI:10.14744/AnatolJCardiol.2024.3871.
• [39]Watanabe H,Iwanaga Y,Miyaji Y,et al.Renal denervation mitigates cardiac remodeling and renal damage in Dahl rats:acomparison with β-receptor blockade[J].Hypertens Res,2016,39(4):217-226.DOI:10.1038/hr.2015.133.
• [40]Jiang W,Chen C,Huo J,et al.Comparison between renal denervation and metoprolol on the susceptibility of ventricular arrhythmias in rats with myocardial infarction[J].Sci Rep,2018,8(1):10206.DOI:10.1038/s41598-018-28562-z.
• [41] Yu L,Huang B,Zhou X,et al.Renal sympathetic stimulation and ablation affect ventricular arrhythmia by modulating autonomic activity in a cesium-induced long QT canine model[J].Heart Rhythm,2017,14(6):912-919.DOI:10.1016/j.hrthm.2017.02.010.
• [42]Davies JE,Manisty CH,Petraco R,et al.First-in-man safety evaluation of renal denervation for chronic systolic heart failure:primary outcome from REACH-Pilot study[J].Int J Cardiol,2013,162(3):189-192.DOI:10.1016/j.ijcard.2012.09.019.
• [43] Gao JQ,Yang W,Liu ZJ.Percutaneous renal artery denervation in patients with chronic systolic heart failure:a randomized controlled trial[J].Cardiol J,2019,26(5):503-510.DOI:10.5603/CJ.a2018.0028.
• [44]Chen W,Ling Z,Xu Y,et al.Preliminary effects of renal denervation with saline irrigated catheter on cardiac systolic function in patients with heart failure:a prospective,randomized,controlled,pilot study[J].Catheter Cardiovasc Interv,2017,89(4):E153-E161.DOI:10.1002/ccd.26475.
• [45] Fukuta H,Goto T,Wakami K,et al.Effects of catheter-based renal denervation on heart failure with reduced ej ection fraction:a meta-analysis of randomized controlled trials[J].Heart Fail Rev,2022,27(1):29-36.DOI:10.1007/s10741-020-09974-4.
• [46]Xia Z,Han L,Pellegrino PR,et al.Safety and efficacy of renal denervation in patients with heart failure with reduced ejection fraction(HFrEF):a systematic review and meta-analysis[J].Heliyon,2022,8(1):e08847.DOI:10.1016/j.heliyon.2022.e08847.
• [47]Gao JQ,Xie Y,Yang W,et al.Effects of percutaneous renal sympathetic denervation on cardiac function and exercise tolerance in patients with chronic heart failure[J].Rev Port Cardiol,2017,36(1):45-51.DOI:10.1016/j.repc.2016.07.007.
• [48]Hopper I,Gronda E,Hoppe UC,et al.Sympathetic response and outcomes following renal denervation in patients with chronic heart failure:12-month outcomes from the Symplicity HF feasibility study[J].J Card Fail,2017,23(9):702-707.DOI:10.1016/j.cardfail.2017.06.004.
• [49]Dai Q,Lu J,Wang B,et al.Effect of percutaneous renal sympathetic nerve radiofrequency ablation in patients with severe heart failure[J].Int J Clin Exp Med,2015,8(6):9779-9785.
• [50]Sharp TE 3rd,Lefer D J.Renal denervation to treat heart failure[J].Annu Rev Physiol,2021,83:39-58.DOI:10.1146/annurev-physiol-031620-093431.
• [51]Subbotina A,Skj??lsvik E,Solbu MD,et al.Echocardiographic findings following renal sympathetic denervation for treatment resistant hypertension,the ReShape CV-risk study[J].Blood Press,2024,33(1):2326298.DOI:10.1080/08037051.2024.2326298.
• [52]Xie L,Li Y,Luo S,et al.Impact of renal denervation on cardiac remodeling in resistant hypertension:a meta-analysis[J].Clin Cardiol,2024,47(2):e24222.DOI:10.1002/clc.24222.
• [53]Rommel KP,Pagoulatou S,Kresoja KP,et al.Modulation of pulsatile left ventricular afterload by renal denervation in heart failure with preserved ejection fraction[J].Circ Heart Fail,2023,16(10):e010543.DOI:10.1161/CIRCHEARTFAILURE.123.010543.
• [54] Pandey A,Shah S J,Butler J,et al.Exercise intolerance in older adults with heart failure with preserved ejection fraction:JACC state-of-the-art review[J].J Am Coll Cardiol,2021,78(11):1166-1187.DOI:10.1016/j.jacc.2021.07.014.
• [55]Kresoja KP,Rommel KP,Fengler K,et al.Renal sympathetic denervation in patients with heart failure with preserved ejection fraction[J].Circ Heart Fail,2021,14(3):e007421.DOI:10.1161/CIRCHEARTFAILURE.120.007421.
• [56]许晓明,夏云龙,夏林莺,等.射血分数保留的心力衰竭非药物治疗进展[J].中国介入心脏病学杂志,2024,32(9):528-534.DOI:10.3969/j.issn.1004-8812.2024.09.007.
• [57]Patel HC,Rosen SD,Hayward C,et al.Renal denervation in heart failure with preserved ejection fraction(RDT-PEF):a randomized controlled trial[J].Eur J Heart Fail,2016,18(6):703-712.DOI:10.1002/ejhf.502.
• [58]Kirstein B,To mala J,Mayer J,et al.Effect of concomitant Renal DeNervation and cardiac ablation on Atrial Fibrillation recurrence-RDN+AF study[J].J Cardiovasc Electrophysiol,2023,34(1):44-53.DOI:10.1111/jce.15714.
• [59]Chinitz L,B??hm M,Evonich R3rd,et al.Long-term changes in atrial arrhythmia burden after renal denervation combined with pulmonary vein isolation:SYMPLICITY-AF[J].JACC Clin Electrophysiol,2024,10(9):2062-2073.DOI:10.1016/j.jacep.2024.04.035.
• [60]Kiu c hi M G,Che n S,H oye NA,et al.Pulmonary vein isolation combined with spironolactone or renal sympathetic denervation in patients with chronic kidney disease,uncontrolled hypertension,paroxysmal atrial fibrillation,and a pacemaker[J].J Interv Card Electrophysiol,2018,51(1):51-59.DOI:10.1007/s10840-017-0302-2.
• [61]Millenaar DN,Mahfoud F,Pavlicek V,et al.First-in-man experience with ultrasound renal denervation for treatment of recurrent ventricular arrhythmias[J].Eur Heart J,2020,41(Supplement 2):ehaa946.2788.DOI:10.1093/ehjci/ehaa946.2788.
• [62] Vakhrushev AD,C ondori Leonardo HI,Goncharova NS,et al.Pulmonary and systemic hemodynamics following multielectrode radiofrequency catheter renal denervation in acutely induced pulmonary arterial hypertension in swine[J].Biomed Res Int,2021,2021:4248111.DOI:10.1155/2021/4248111.
• [63]Liu Q,Song J,Lu D,et al.Effects of renal denervation on monocrotaline induced pulmonary remodeling[J].Oncotarget,2017,8(29):46846-46855.DOI:10.18632/oncotarget.15154.
• [64]Warchol-Celinska E,Prejbisz A,Kadziela J,et al.Renal denervation in resistant hypertension and obstructive sleep apnea:randomized proof-of-concept phaseⅡtrial[J].Hypertension,2018,72(2):381-390.DOI:10.1161/HYPERTENSION AHA.118.11180.
• [65]Shantha GPS,Pancholy SB.Effect of renal sympathetic denervation on apnea-hypopnea index in patients with obstructive sleep apnea:a systematic review and meta-analysis[J].Sleep Breath,2015,19(1):29-34.DOI:10.1007/s11325-014-0991-z.
• [66]Iyer MS,Bergman RN,Korman JE,et al.Renal denervation reverses hepatic insulin resistance induced by high-fat diet[J].Diabetes,2016,65(11):3453-3463.DOI:10.2337/db 16-0698.
• [67]Günes-Altan M,Schmid A,Ott C,et al.Blood pressure reduction after renal denervation in patients with or without chronic kidney disease[J].Clin Kidney J,2023,17(1):sfad237.DOI:10.1093/ckj/sfad237.